NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 709516 | Null | 0.0139796580235794 | -0.068841182 |
NSC 718185 | Null | 0.0139796580235794 | 0.19928584 |
NSC 756134 | GSK1023156A | 0.0139796580235794 | 0.19956203 |
NSC 127128 | Null | 0.0147237897640499 | 0.039445188 |
NSC 625543 | ANTINEOPLASTIC-625543 | 0.0147237897640499 | 0.092006795 |
NSC 634398 | Null | 0.0147237897640499 | -0.085023892 |
NSC 689138 | 1H,3H-Benzo[c]pyrrolo[3,4-a]carbazole-1,3-dione, 2,3a,3b,4,5,6,7,7a-octahydro-2-(4-methoxyphenyl)- 5-(1-methylethyl)-9-(phenylmethoxy)- | 0.0147237897640499 | 0.18783792 |
NSC 240529 | 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- | 0.0164116791870036 | 0.7212847 |
NSC 329261 | Null | 0.0164116791870036 | 0.18478928 |
NSC 357704 | Cyanomorpholinodoxorubicin | 0.0164116791870036 | 0.67909613 |